Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension treatment guidelines: practical implications.

Kenneth L Choi1, George L Bakris

  • 1Rush Hypertension Center, Department of Preventive Medicine, Rush University Medical Center, Chicago, IL 60612, USA.

Seminars in Nephrology
|October 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factitious acidosis and severe hypoalbuminemia caused by unsuspected assay interference.

Clinical kidney journal·2021
Same author

Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.

British journal of pharmacology·2021
Same author

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.

Circulation·2021
Same author

Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.

Journal of the American Society of Nephrology : JASN·2021
Same author

Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects.

Nature reviews. Nephrology·2021
Same author

Longitudinal Blood Pressure Patterns and Chronic Kidney Disease Progression: An Evolving Paradigm.

Hypertension (Dallas, Tex. : 1979)·2021

Lowering blood pressure (BP) is key to preventing cardiovascular and renal events. Guidelines recommend specific BP goals, especially for patients with diabetes or kidney disease, often requiring multiple medications.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Management

Background:

  • Blood pressure lowering aims to prevent cardiovascular and renal events.
  • Current guidelines from major health organizations emphasize BP control.
  • Specific BP targets are set for the general hypertensive population and those with comorbidities.

Purpose of the Study:

  • To outline current guidelines for blood pressure management.
  • To define target blood pressure goals for various patient populations.
  • To highlight the role of specific antihypertensive agents and combination therapy.

Main Methods:

  • Review of recent guideline statements (JNC7, ADA, ESH, KDOQI).
  • Analysis of meta-analyses of clinical trials with renal endpoints.

Related Experiment Videos

  • Synthesis of recommendations for antihypertensive agent initiation and combination therapy.

    • Main Results:

    • General goal BP <140/90 mm Hg; lower goal <130/80 mm Hg for diabetes/kidney disease.
    • Proteinuria (≥1g) necessitates BP near 115 mm Hg to slow nephropathy.
    • Initiation with 2 agents recommended if systolic BP is >20 mm Hg above goal.

    Conclusions:

    • Achieving BP goals, especially in kidney disease, often requires multiple agents.
    • Combination therapy, including a diuretic and RAAS blocker, is crucial for kidney disease patients.
    • Tailored antihypertensive strategies are essential for preventing cardiovascular and renal complications.